Header Logo

Connection

EVELYNE M LOYER to Hormone Antagonists

Back to Details
This is a "connection" page, showing publications EVELYNE M LOYER has written about Hormone Antagonists.
EVELYNE M LOYER
Connection Strength
0.057
Hormone Antagonists
  1. Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer. Gynecol Oncol. 2003 Sep; 90(3):552-9.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.